Woo Raymond sold $48K of CBLL
Woo Raymond (Chief Technology Officer) sold 1,979 shares of Ceribell, Inc. (CBLL) at $24.02 on 2026-08-21.
How this was made
The 30-second read
Why it matters
The disclosed sale is unlikely to affect Ceribell's valuation significantly, but it provides transparency for investors monitoring insider activity.
Market read
Routine insider sale with limited market impact; useful for compliance monitoring.
What to watch
The insider retains a large position; the transaction size is trivial compared to market volume.
Background
SEC Form 4 filing discloses insider transactions. Ceribell is a publicly traded medical device company.
Ticker impact
CTO Woo Raymond sold 1,979 shares of Ceribell for $47,535.58, reducing his stake to 194,729 shares.
Potential short-term downward pressure of a few cents, unlikely to move the stock materially.
The sale represents less than 1% of the insider's remaining position and is under $50k, limiting market impact.
Market effects
Minor effect on biotech/healthcare sector sentiment.
US market only.
Low
Counterpoint
Sale could be routine liquidity need, not a lack of confidence.
Key entities
- CompanyCeribell, Inc.
US-listed biotech firm (ticker CBLL).
- IndividualWoo Raymond
Chief Technology Officer of Ceribell.